Association between Second-Hand Exposure to E-Cigarettes at Home and Exacerbations in Children with Asthma.
Serena CostantinoArianna TorreSimone Foti RandazzeseSalvatore Antonio MollicaFederico MottaDomenico BuscetiFederica FerranteLucia CaminitiGiuseppe CrisafulliSara MantiPublished in: Children (Basel, Switzerland) (2024)
Several studies have shown the effects of e-cigarettes in adults. Nowadays, few data are available in the pediatric population. This study aims to assess the relationship between asthma exacerbations and home exposure to e-cigarettes. We conducted a pilot, retrospective, monocenter, observational study. Demographic and clinical data were collected, including number of asthma exacerbations, need for rescue therapy and/or therapeutic step-up, and Asthma Control Test (ACT) and children-Asthma Control Test (c-ACT) scores. The cohort consisted of 54 patients (5-17 years old), divided into two groups: A, including patients exposed to e-cigarette aerosols; B, including unexposed patients. The statistical analysis showed no relevant variation in the number of asthma symptomatic days and need for rescue therapy in group A versus group B ( p = 0.27 and 0.19, respectively). There were no statistically significant variations when also considering the number of patients who needed a therapeutic step-up ( p = 0.3). The mean values of ACT and c-ACT were, respectively, 17.2 ± 7.6 and 18.3 ± 5.6 in group A and 19.6 ± 3.8 and 14.6 ± 5.8 in group B ( p = 0.3 and 0.4, respectively). Although we did not find a statistically significant correlation between second-hand e-cigarette exposure and asthma exacerbations, our findings suggest that asthmatic children exposed second-hand to e-cigarettes may have increased risk of asthma symptomatic days. Future research is warranted.
Keyphrases
- chronic obstructive pulmonary disease
- lung function
- end stage renal disease
- smoking cessation
- cystic fibrosis
- newly diagnosed
- ejection fraction
- chronic kidney disease
- allergic rhinitis
- young adults
- peritoneal dialysis
- replacement therapy
- clinical trial
- patient reported outcomes
- randomized controlled trial
- big data
- cross sectional
- cell therapy